Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Virginia Devonshire

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Neurology|September 27, 2006
Is late-onset multiple sclerosis associated with a worse outcome?Helen Tremlett, Virginia Devonshire
Neurology|December 29, 2005
The natural history of primary progressive MS in British Columbia, CanadaHelen Tremlett, Donald Paty, Virginia Devonshire
Neurology|January 26, 2006
Disability progression in multiple sclerosis is slower than previously reportedHelen Tremlett, Donald Paty, Virginia Devonshire
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2008
Natural history of secondary-progressive multiple sclerosisHelen Tremlett, Yinshan Zhao, Virginia Devonshire
Journal of Neurology|March 25, 2009
Natural history comparisons of primary and secondary progressive multiple sclerosis reveals differences and similaritiesHelen Tremlett, Yinshan Zhao, Virginia Devonshire, et al.
Neurology|February 14, 2007
Longitudinal follow-up of "benign" multiple sclerosis at 20 yearsAna-Luiza Sayao, Virginia Devonshire, Helen Tremlett
Therapeutic Advances in Neurological Disorders|December 25, 2010
Escalating immunotherapy of multiple sclerosisPeter Rieckmann, Anthony Traboulsee, Virginia Devonshire, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 17, 2011
The psychosocial and cognitive impact of longstanding 'benign' multiple sclerosisAna-Luiza Sayao, Anna-Marie Bueno, Virginia Devonshire, et al.
Journal of Neurology|March 12, 2018
Monitoring and management of autoimmunity in multiple sclerosis patients treated with alemtuzumab: practical recommendationsVirginia Devonshire, Richard Phillips, Hilary Wass, et al.
Multiple Sclerosis and Related Disorders|April 22, 2022
Pregnancy outcomes of women with multiple sclerosis treated with ocrelizumab in Canada: A descriptive analysis of real-world dataVictor Gitman, Aphrodite Stavropoulos, Victoria Saenz, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Neurology|September 27, 2006
Is late-onset multiple sclerosis associated with a worse outcome?Helen Tremlett, Virginia Devonshire
Neurology|December 29, 2005
The natural history of primary progressive MS in British Columbia, CanadaHelen Tremlett, Donald Paty, Virginia Devonshire
Neurology|January 26, 2006
Disability progression in multiple sclerosis is slower than previously reportedHelen Tremlett, Donald Paty, Virginia Devonshire
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2008
Natural history of secondary-progressive multiple sclerosisHelen Tremlett, Yinshan Zhao, Virginia Devonshire
Journal of Neurology|March 25, 2009
Natural history comparisons of primary and secondary progressive multiple sclerosis reveals differences and similaritiesHelen Tremlett, Yinshan Zhao, Virginia Devonshire, et al.
Neurology|February 14, 2007
Longitudinal follow-up of "benign" multiple sclerosis at 20 yearsAna-Luiza Sayao, Virginia Devonshire, Helen Tremlett
Therapeutic Advances in Neurological Disorders|December 25, 2010
Escalating immunotherapy of multiple sclerosisPeter Rieckmann, Anthony Traboulsee, Virginia Devonshire, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 17, 2011
The psychosocial and cognitive impact of longstanding 'benign' multiple sclerosisAna-Luiza Sayao, Anna-Marie Bueno, Virginia Devonshire, et al.
Journal of Neurology|March 12, 2018
Monitoring and management of autoimmunity in multiple sclerosis patients treated with alemtuzumab: practical recommendationsVirginia Devonshire, Richard Phillips, Hilary Wass, et al.
Multiple Sclerosis and Related Disorders|April 22, 2022
Pregnancy outcomes of women with multiple sclerosis treated with ocrelizumab in Canada: A descriptive analysis of real-world dataVictor Gitman, Aphrodite Stavropoulos, Victoria Saenz, et al.
Pageof 4